ONTARIO, Calif., Oct. 19, 2017 -- Perfectus Aluminum Inc. has issued the following: On October 12, 2017 the Aluminum Extruders Council (AEC), an industry group representing largely American aluminum extruders, posted to its blog a false narrative regarding a suit to which Perfectus Aluminum Inc. is a related party. The government is not “seeking unpaid duties from Perfectus for goods brought into the country.” Rather, the government is attempting to use a 2017 Department of Commerce determination to assess retroactive antidumping duties on goods imported as early as 2011. It is discouraging that AEC would tout such an obviously egregious government overstep as a “victory” to their members and the industry: were it one of AEC’s own members facing such an obvious violation of fair play and due process, it would rightfully argue that government overreach is a threat to manufacturers everywhere.
In addition to the hypocrisy of the AEC’s promotion of this case, its stance on the underlying issues warrant serious scrutiny. AEC’s position, which it has articulated in numerous filings before the Department of Commerce, is that permitting Perfectus’ product to enter the American stream of commerce would, in AEC’s words, “harm U.S. producers.” It bears repeating that at the time Perfectus’ products were detained—in direct response to AEC’s victory before Commerce—they were in a port leaving the United States. If the AEC gets its wish and Perfectus’ goods are indeed forfeited, they would be liquidated and would, by law, be released in some form into the open market: the very outcome AEC purports to fear most.
Finally, allegations do not equate to guilt. Cherry-picking language from a civil complaint to promote a false narrative is both unethical and untruthful. To this end, Perfectus has attached its filing, in its entirety, at the end of this release.
Please address any questions to Harris, Baio & McCullough at 215-440-9800.
A link to the PDF is available here: http://www.globenewswire.com/NewsRoom/AttachmentNg/d8d784b3-d89d-4b14-bbdc-a453d13731d8


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate 



